Fighting ovarian cancer: New study gives hope – mRNA active ingredient kills tumors. Every year in Germany around 7,300 women suffer from ovarian cancer.
The p53 gene is mutated in 96 percent of ovarian cancer patients. Researchers have developed an mRNA in the laboratory with a blueprint for a flawless protein. This artificial mRNA, packaged in fatty vesicles, was brought together with cultures of human cancer cells. After treatment, these shrank and even began to die. The mRNA was also tested on mice. The tumors in the ovaries also almost completely disappeared in the animals.